MAUDE MDR 8180347

MDR report key
8180347
Report number
2245578-2018-00317
Event key
0
Event type
3
Date of event
2018-11-27
Date received
2018-12-19
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
100
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
LINDA MACZUSZENKO
Address
400 COLLEGE ROAD PRINCETON NJ 08540 US
Phone
613-613-6136
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1I-STAT CG4+ CARTRIDGECG4+ CARTRIDGEABBOTT POINT OF CAREKHPNA03P85-25Y N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12018-12-1901. D

Event Narratives#

N

Patient 1

APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

D

Patient 1

ON 12/07/2018, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT CG4+ CARTRIDGES (LOT# UNK) THAT YIELDED SUSPECTED DISCREPANT RESULTS ON AN (B)(6) PATIENT WITH DIABETES. THE CUSTOMER STATED THAT THE PATIENT WAS ALREADY VERY CRITICAL WHEN ADMITTED AND LATER EXPIRED. CAUSE OF DEATH IS UNKNOWN AT THE TIME OF THIS REPORT. THERE WAS NO ADDITIONAL PATIENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT. METHOD, DATE, RESULT, SAMPLE: I-STAT, (B)(6) 2018,

N

Patient 1

APOC INCIDENT # (B)(4). THE INVESTIGATION WAS COMPLETED ON 02/19/2019. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THE CARTRIDGE LOT MET FINISHED GOODS (FG) RELEASE CRITERIA. RETAINED TESTING MET THE ACCEPTANCE CRITERIA OUTLINED IN APPENDIX 1 OF Q04.01.003 REV. AC (PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE). NO DEFICIENCY HAS BEEN DETERMINED FOR CG4+ LOT M18163A.

D

Patient 1